4//SEC Filing
Intra-Cellular Therapies, Inc. 4
Accession 0001181431-14-025923
CIK 0001567514operating
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:52 PM ET
Size
5.0 KB
Accession
0001181431-14-025923
Insider Transaction Report
Form 4
Rawlins Michael
Director
Transactions
- Award
Stock Option (right to buy)
2014-06-30+20,000→ 20,000 totalExercise: $16.86From: 2015-06-30Exp: 2024-06-30→ Common Stock (20,000 underlying)
Issuer
Intra-Cellular Therapies, Inc.
CIK 0001567514
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001567514
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 4:52 PM ET
- Size
- 5.0 KB